UNIVERSITY OF KENTUCKY
Targeting Lung Fibrosis Using Epigenetic Therapy
Targeting Lung Fibrosis Using Epigenetic Therapy is a funding opportunity from UNIVERSITY OF KENTUCKY, up to 698070, closing July 31, 2028.
Jul 31, 2028
(731d left)Overview
PROJECT SUMMARY Pulmonary fibrosis is a complex disease that limits lung function through development of collagen-rich scar tissue. Although there are currently two FDA-approved therapies for fibrosis patients, these drugs are capable of extending life only months and do not reverse the progression of the disease. The…